Stock KRSA3 KORA SAÚDE PARTICIPAÇÕES S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Kora Saúde Participações S.A.

Equities

KRSA3

BRKRSAACNOR0

Market Closed - Sao Paulo
Other stock markets
 04:07:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.86 BRL +14.67% Intraday chart for Kora Saúde Participações S.A. +13.16% -33.85%
Feb. 28 Transcript : Kora Saúde Participações S.A., Q4 2023 Earnings Call, Feb 28, 2024
Feb. 27 Kora Saúde Participações S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • Low profitability weakens the company.
  • One of the major weak points of the company is its financial situation.
  • The company is not the most generous with respect to shareholders' compensation.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
KORA SAÚDE PARTICIPAÇÕES S.A. Stock Kora Saúde Participações S.A.
-33.85% 129M -
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-20.16% 16.21B
B+
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
+4.50% 12.44B
B
IHH HEALTHCARE Stock IHH Healthcare
+3.98% 11.58B
B+
APOLLO HOSPITALS ENTERPRISE LIMITED Stock Apollo Hospitals Enterprise Limited
+9.72% 10.79B
B+
RAMSAY HEALTH CARE LIMITED Stock Ramsay Health Care Limited
-2.19% 7.68B
A-
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
+18.43% 7.2B
D
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+4.49% 6.67B
B-
GLOBAL HEALTH LIMITED Stock Global Health Limited
+50.89% 4.66B -
DALLAH HEALTHCARE COMPANY Stock Dallah Healthcare Company
-5.12% 4.25B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
  1. Stock Market
  2. Equities
  3. KRSA3 Stock
  4. Ratings Kora Saúde Participações S.A.